Trends in the utilization and wastage of coagulation factor concentrates: the application of a regional tracking programme-Reference-Cited by-同舟云学术

Trends in the utilization and wastage of coagulation factor concentrates: the application of a regional tracking programme

Published:2007-05 Issue:3 Volume:13 Page:271-278
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

ARNOLD D. M.,WEBERT K. E.,CARRUTHERS J.,ALMONTE T.,DECKER K.,SEROSKI W.,REED J.,CHAN A. K. C.,PAI M.,WALKER I.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2007.01452.x/fullpdf

Reference15 articles.

1. Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up

2. Effect of using safer blood products on prevalence of HIV infection in haemophilic Canadians. Canadian Hemophilia Clinic Directors Group.

3. Hepatitis C Infection in Patients With Hemophilia: Results of a National Survey

4. 4 Health Canada . Krever Commission Report. Public Works and Government Services, Ottawa, Canada, 1997 . Available at: http://www.hc-sc.gc.ca/ahc-asc/activit/com/krever_e.html (accessed on 7 January 2007).

5. Proceedings of a consensus conference: the screening of blood donors for variant CJD1 1This Consensus Conference took place at the Ritz Carlton Hotel in Montreal, Quebec, on March 26–28, 2003, and was chaired by Dr. Gilles Delage of Héma Québec.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective;Saudi Pharmaceutical Journal;2023-12

2. A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third-generation B-domain-deleted recombinant factor VIII;Haemophilia;2018-02-01

3. Utilization Patterns of Coagulation Factor Consumption for Patients with Hemophilia;J KOREAN MED SCI;2016

4. Impact of an innovative blood factor stewardship program on drug expense and patient care;American Journal of Health-System Pharmacy;2015-09-15

5. First analysis of 10‐year trends in national factor concentrates usage in haemophilia: data from CHARMS , the Canadian Hemophilia Assessment and Resource Management System;Haemophilia;2014-06-20